← Back
$HALO All transactions

HALOZYME THERAPEUTICS, INC.

M 10b5-1 Plan

$ Value

$162K

Shares

20,000

Price

$8

Filed

Jul 10

Insider

Name

Torley Helen

Title

PRESIDENT AND CEO

CIK

0001528185

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-09

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

753,719

Footnotes

The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $54.17 to $55.13. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $55.17 to $56.16. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $56.055 to $57.00. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $57.05 to $57.10. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $56.184 to $57.17. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $57.185 to $57.94. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 3, 2016.

Filing Info

Accession No.

0001415889-25-019653

Form Type

4

Issuer CIK

0001159036

Torley Helen's History

Date Ticker Type Value
2026-04-06 HALO M $121K
2026-04-06 HALO $373K
2026-04-06 HALO $262K
2026-04-06 HALO M $121K
2026-04-02 HALO M $241K
2026-04-02 HALO $1.0M
2026-04-02 HALO $273K
2026-04-02 HALO M $241K
2026-04-01 HALO M $241K
2026-04-01 HALO $1.2M

Other Insiders at HALO (90d)

Insider Bought Sold Last
RAMSAY DAVID A
Interim CFO
2026-04-01
Torley Helen
PRESIDENT AND CEO
$3.2M 2026-04-06